The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Wed., Feb. 26, 2:30 PM

Slide #72. Revive Therapeutics Ltd. Psilocin Pharma Corp.

Acquirer: Revive Therapeutics Ltd. (RVVTF)
Acquiree: Psilocin Pharma Corp.
Details: Revive Therapeutics Ltd. ("Revive" or the "Company") is pleased to announce that it has entered into a letter of intent, dated February 11, 2020 (the "LOI") with Psilocin Pharma Corp. ("Psilocin"), an arm's length party incorporated pursuant to the laws of the Province of Ontario. Pursuant to the terms of the LOI, Revive will acquire all of the issued and outstanding securities of Psilocin (the "Proposed Acquisition") for an aggregate purchase price of $2.75 million (the "Purchase Price"). The Purchase Price will be satisfied through the issuance of an aggregate of 55 million common shares in the capital of Revive at a deemed price of $0.05 per share.

Revive Therapeutics is engaged in the development and commercialization of drugs for underserved medical needs. Co. is focused on acquiring, developing and commercializing treatments for major market opportunities such as sleep apnea, gout and rare diseases. Co. also aims to bring drugs to the market by finding new uses for old drugs, also known as drug repurposing, and improving the therapeutic performance of existing drugs for underserved medical needs.

Open the RVVTF Page at The Online Investor »

Company Name: 
Revive Therapeutics Ltd
Drugs & Pharmaceuticals

Open the RVVTF Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Mergers & Acquisitions Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.